Effects of Adrenaline Infiltration on Surgical Field of View in Endoscopic Sinus Surgery
Intraoperative Bleeding
About this trial
This is an interventional treatment trial for Intraoperative Bleeding
Eligibility Criteria
Inclusion Criteria: Diagnosed with recurrent acute or chronic rhinosinusitis recalcitrant to medical treatment and scheduled for endoscopic sinus surgery Exclusion Criteria: Patients who have asymetrical disease on the two sides (Lund Mackay score difference more than 2) Patients who have endoscopic sinus surgery for treatment of tumor or disease other than sinusitis Patients with underlying uncontrolled hypertension Patients with bleeding disorder or are unable to discontinue antiplatelet or anticoagulant before the surgery Patients who are allergic to adrenaline or to xylocaine
Sites / Locations
- Stanford
Arms of the Study
Arm 1
Experimental
Endoscopic sinus surgery
Participants receive topical 1:1000 epinephrine plus saline in one nostril, and topical 1:1000 epinephrine plus infiltration of 1% lidocaine with 1:100,000 epinephrine in the other nostril, during endoscopic visualization while undergoing Endoscopic sinus surgery (ESS).